Patients undergoing coronary artery bypass surgery. Atherosclerotic heart disease of native coronary artery
Conditions
Interventions
Intervention 1: Intervention group: When the patient is discharged from the inpatient department, the informed consent form and the clinical and demographic information questionnaire and the phone num
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: The patient has recently undergone CABG The patient should be willing to learn and participate in the study Ability to use mobile platforms and have access to the Internet The patient must be a resident of Hamadan province Have a weak or moderate level of self-efficacy in primary results The patient should have at least primary education No mental illness or movement and learning limitations The patient must consent to participate in the research Be in the age range of 30 to 70 years
Exclusion criteria
Exclusion criteria: The patient be over 80 years old Participate in another educational program in the last 6 months Have severe hearing and vision disorders The patient is not literate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Self-efficacy. Timepoint: Before the intervention, 45 days and again 75 days after discharge from the hospital. Method of measurement: Using the Cardiovascular disease management Self-efficacy questionnaire of Esteka et al.: The Cardiovascular disease management Self-efficacy questionnaire was designed and compiled by Esteka et al. In (2015) in order to measure the Self-efficacy of Cardiovascular disease management. This questionnaire has 9 questions and 3 components of heart risk Self-efficacy,Treatment adherence Self-efficacy and symptom recognition Self-efficacy and based on the Likert spectrum with questions such as (you can avoid life Problems and Difficult situations and daily stress well) minimize) measures the Self-efficacy of Cardiovascular disease management. The Distribution of questionnaire questions is such that questions 1 to 4 examine the Self-efficacy of cardiac risk, questions 5 and 6 examine the Self-efficacy of following treatment, and questions 7, 8, and 9 examine the Self-efficacy of diagnosing symptoms. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Amirlohesari
Hamedan University of Medical Sciences
Outcome results
None listed